US Patent Issued on Jan. 20 for "Method of inhibiting kinase by mesylate salts of triazolopyrazine derivatives" (South Korean Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,817, issued on Jan. 20.

"Method of inhibiting kinase by mesylate salts of triazolopyrazine derivatives" was invented by Jun Young Choi (Seoul, South Korea), Kyung-eui Park (Seoul, South Korea) and Na Young Kim (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are a salt (mesylate salt) of methanesulfonic acid and a triazolopyrazine derivative of formula (1), pharmaceutical compositions thereof, methods of making the salt, and therapeutic use thereof:"

The patent was filed on Dec. 26, 2023, under Application No. 18/395,741.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov...